Technology area: Medical Devices & Mechanical Engineering
10 pending office actions • 4 art units • 9 examiners • 0 of 10 (0%) have an AI response strategy ready • 6 patents granted in the last 365 days
Galvani Bioelectronics Limited manages a patent portfolio in the Medical Devices & Mechanical Engineering technology area. The company has 10 pending office actions. These actions are distributed across 4 distinct art units, indicating that the portfolio covers several different technical sub-specialties within medical device engineering. The presence of 4 distinct art units suggests that the company's technology is being evaluated by multiple specialized groups within the USPTO.
The prosecution involves 9 distinct examiners. Tammie K Marlen is the busiest examiner for the company, with 2 pending office actions. With 10 pending actions and 9 examiners, the company's legal strategy involves a broad distribution of matters across many different individuals at the USPTO. This distribution means that almost every pending office action is being reviewed by a unique examiner, with Tammie K Marlen being the only examiner assigned to more than one matter.
Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (10%) |
| §103 only | 1 (10%) |
| §102 only | 1 (10%) |
| §112 only | 1 (10%) |
| Double-patenting + other | 2 (20%) |
| Multi-statute (no §101) | 3 (30%) |
| No statute on record | 1 (10%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MARLEN, TAMMIE K | 2 | 75.2% | +21.0% |
| GHAND, JENNIFER LEIGH-STEWAR | 1 | 60.5% | +27.8% |
| MOSS, JAMES R | 1 | 51.1% | +41.6% |
| LEE, ERICA SHENGKAI | 1 | 65.4% | +30.1% |
| ALTER MORSCHAUSER, ALYSSA MARGO | 1 | 76.5% | +15.8% |
| PATEL, NIKETA I | 1 | 41.1% | +8.3% |
| HUSSAINI, ATTIYA SAYYADA | 1 | 60.0% | +16.1% |
| HOAG, MITCHELL BRAIN | 1 | 70.4% | +18.8% |
| BAKKAR, AYA ZIAD | 1 | 63.3% | +43.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18682265 | Neuromodulation Device | MARLEN, TAMMIE K | 63d |
| 17780195 | ELECTRODE DEVICES FOR NEUROSTIMULATION AND RELATED METHODS | HUSSAINI, ATTIYA SAYYADA | — |
| 17780210 | SYSTEMS AND METHODS FOR LAPAROSCOPIC DELIVERY AND DEPLOYMENT OF A NEURAL INTERFACE | HOAG, MITCHELL BRAIN | — |
| 17593664 | PSEUDO-MONOPOLAR NEURAL INTERFACE SYSTEM | BAKKAR, AYA ZIAD | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18537151 | Neuromodulation Device | MARLEN, TAMMIE K | 120d overdue |
| 18682265 | Neuromodulation Device | MARLEN, TAMMIE K | 63d |
| 19172332 | STIMULATION OF A NERVE SUPPLYING THE SPLEEN | GHAND, JENNIFER LEIGH-STEWAR | — |
| 19082435 | ELECTRODE DEVICES FOR NEUROSTIMULATION | MOSS, JAMES R | — |
| 18930609 | Treatment of Disorders Associated with Inflammation | LEE, ERICA SHENGKAI | — |
| 18924183 | Neuromodulation of Ganglia | ALTER MORSCHAUSER, ALYSSA MARGO | — |
| 17780195 | ELECTRODE DEVICES FOR NEUROSTIMULATION AND RELATED METHODS | HUSSAINI, ATTIYA SAYYADA | — |
| 17780210 | SYSTEMS AND METHODS FOR LAPAROSCOPIC DELIVERY AND DEPLOYMENT OF A NEURAL INTERFACE | HOAG, MITCHELL BRAIN | — |
| Art Unit | Apps |
|---|---|
| 3796 | 2 |
| 3700 | 2 |
| 3792 | 1 |
| 3771 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19172332 | STIMULATION OF A NERVE SUPPLYING THE SPLEEN | GHAND, JENNIFER LEIGH-STEWAR | — | §103DP | Non-Final OA | — | Pending | Apr 07, 2025 |
| 19082435 | ELECTRODE DEVICES FOR NEUROSTIMULATION | MOSS, JAMES R | — | §103§112DP | Non-Final OA | — | Pending | Mar 18, 2025 |
| 18930609 | Treatment of Disorders Associated with Inflammation | LEE, ERICA SHENGKAI | — | §112Other | Non-Final OA | — | Pending | Oct 29, 2024 |
| 18924183 | Neuromodulation of Ganglia | ALTER MORSCHAUSER, ALYSSA MARGO | — | §102Other | Non-Final OA | — | Pending | Oct 23, 2024 |
| 18742863 | NERVE STIMULATION SYSTEM | PATEL, NIKETA I | 3792 | Other | Non-Final OA | 7d | Pending | Jun 13, 2024 |
| 18682265 | Neuromodulation Device | MARLEN, TAMMIE K | 3796 | §101§102§103§112 | Non-Final OA | 63d | Pending | Feb 08, 2024 |
| 18537151 | Neuromodulation Device | MARLEN, TAMMIE K | 3796 | §103 | Final Rejection | 120d overdue | Pending | Dec 12, 2023 |
| 17780195 | ELECTRODE DEVICES FOR NEUROSTIMULATION AND RELATED METHODS | HUSSAINI, ATTIYA SAYYADA | 3700 | §102§103§112 | Non-Final OA | — | Pending | May 26, 2022 |
| 17780210 | SYSTEMS AND METHODS FOR LAPAROSCOPIC DELIVERY AND DEPLOYMENT OF A NEURAL INTERFACE | HOAG, MITCHELL BRAIN | 3771 | §103§112 | Non-Final OA | — | Pending | May 26, 2022 |
| 17593664 | PSEUDO-MONOPOLAR NEURAL INTERFACE SYSTEM | BAKKAR, AYA ZIAD | 3700 | §102§103 | Final Rejection | — | Pending | Sep 22, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial